$EXPI
EXP World Holdings, Inc.

2023 Q3 Form 10-Q Financial Statement

#000155837023017439 Filed on November 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2022 Q3
Revenue $1.215B $1.239B
YoY Change -1.97% 11.57%
Cost Of Revenue $1.131B $1.146B
YoY Change -1.3% 11.15%
Gross Profit $83.60M $93.12M
YoY Change -10.23% 17.07%
Gross Profit Margin 6.88% 7.52%
Selling, General & Admin $81.76M $93.10M
YoY Change -12.17% 36.15%
% of Gross Profit 97.8% 99.97%
Research & Development $15.48M
YoY Change
% of Gross Profit 18.52%
Depreciation & Amortization $2.790M $2.767M
YoY Change 0.83% 63.34%
% of Gross Profit 3.34% 2.97%
Operating Expenses $1.213B $1.239B
YoY Change -2.12% 12.7%
Operating Profit $1.863M $26.00K
YoY Change 7065.38% -99.77%
Interest Expense -$400.0K -$329.0K
YoY Change 21.58% -16550.0%
% of Operating Profit -21.47% -1265.38%
Other Income/Expense, Net $354.0K -$251.0K
YoY Change -241.04% 5.91%
Pretax Income $2.217M -$225.0K
YoY Change -1085.33% -102.06%
Income Tax $868.0K -$4.627M
% Of Pretax Income 39.15%
Net Earnings $1.349M $4.402M
YoY Change -69.35% -81.52%
Net Earnings / Revenue 0.11% 0.36%
Basic Earnings Per Share $0.01 $0.03
Diluted Earnings Per Share $0.01 $0.03
COMMON SHARES
Basic Shares Outstanding 153.8M 151.8M
Diluted Shares Outstanding 158.2M 155.9M

Balance Sheet

Concept 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $120.1M $134.5M
YoY Change -10.74% 37.2%
Cash & Equivalents $120.1M $134.5M
Short-Term Investments
Other Short-Term Assets $66.30M $65.82M
YoY Change 0.73% -15.87%
Inventory
Prepaid Expenses
Receivables $113.3M $119.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $299.8M $320.2M
YoY Change -6.36% 4.59%
LONG-TERM ASSETS
Property, Plant & Equipment $13.86M $17.69M
YoY Change -21.63% 34.15%
Goodwill $24.88M $26.51M
YoY Change -6.17% 104.82%
Intangibles $11.46M $8.975M
YoY Change 27.67% 16.66%
Long-Term Investments
YoY Change
Other Assets $72.80M $65.29M
YoY Change 11.51% 67.28%
Total Long-Term Assets $123.1M $120.7M
YoY Change 1.96% 59.86%
TOTAL ASSETS
Total Short-Term Assets $299.8M $320.2M
Total Long-Term Assets $123.1M $120.7M
Total Assets $422.9M $440.9M
YoY Change -4.08% 15.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.300M $9.911M
YoY Change -6.16% 15.85%
Accrued Expenses $108.4M $117.6M
YoY Change -7.84% 6.65%
Deferred Revenue $54.21M $52.65M
YoY Change 2.96% -24.14%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $171.9M $180.4M
YoY Change -4.68% -4.81%
LONG-TERM LIABILITIES
Long-Term Debt $5.000K $2.714M
YoY Change -99.82% 56.34%
Other Long-Term Liabilities $0.00 $720.0K
YoY Change -100.0% -15.19%
Total Long-Term Liabilities $5.000K $2.714M
YoY Change -99.82% 56.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $171.9M $180.4M
Total Long-Term Liabilities $5.000K $2.714M
Total Liabilities $171.9M $183.8M
YoY Change -6.46% -4.3%
SHAREHOLDERS EQUITY
Retained Earnings $11.97M $34.62M
YoY Change -65.43% 66.42%
Common Stock $757.0M $567.6M
YoY Change 33.37% 63.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $249.8M $255.9M
YoY Change
Total Liabilities & Shareholders Equity $422.9M $440.9M
YoY Change -4.08% 15.52%

Cashflow Statement

Concept 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income $1.349M $4.402M
YoY Change -69.35% -81.52%
Depreciation, Depletion And Amortization $2.790M $2.767M
YoY Change 0.83% 63.34%
Cash From Operating Activities $22.30M $22.03M
YoY Change 1.24% -28.92%
INVESTING ACTIVITIES
Capital Expenditures $1.500M -$1.145M
YoY Change -231.0% -67.75%
Acquisitions
YoY Change
Other Investing Activities $200.0K -$9.668M
YoY Change -102.07% 221.84%
Cash From Investing Activities -$1.300M -$10.81M
YoY Change -87.98% 64.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -59.90M -65.17M
YoY Change -8.08% 12.34%
NET CHANGE
Cash From Operating Activities 22.30M 22.03M
Cash From Investing Activities -1.300M -10.81M
Cash From Financing Activities -59.90M -65.17M
Net Change In Cash -38.90M -53.95M
YoY Change -27.9% 60.7%
FREE CASH FLOW
Cash From Operating Activities $22.30M $22.03M
Capital Expenditures $1.500M -$1.145M
Free Cash Flow $20.80M $23.17M
YoY Change -10.23% -32.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001495932
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38493
dei Entity Registrant Name
EntityRegistrantName
EXP WORLD HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0681092
dei Entity Address Address Line1
EntityAddressAddressLine1
2219 Rimland Drive, Suite 301
dei Entity Address City Or Town
EntityAddressCityOrTown
Bellingham
dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98226
dei City Area Code
CityAreaCode
360
dei Local Phone Number
LocalPhoneNumber
685-4206
dei Security12b Title
Security12bTitle
Common Stock, $0.00001 par value per share
dei Trading Symbol
TradingSymbol
EXPI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
153798815
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120141000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121594000
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
54000000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
37789000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1803000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4014000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
113344000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
87262000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12325000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8468000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
299810000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
255113000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13862000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18151000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2127000
CY2023Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
7598000
CY2022Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1703000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11458000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8700000
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
65241000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
68676000
CY2023Q3 us-gaap Goodwill
Goodwill
24879000
CY2022Q4 us-gaap Goodwill
Goodwill
27212000
CY2023Q3 us-gaap Assets
Assets
422862000
CY2022Q4 us-gaap Assets
Assets
381682000
CY2023Q3 expi Accounts Payable Prepaid Current
AccountsPayablePrepaidCurrent
9322000
CY2022Q4 expi Accounts Payable Prepaid Current
AccountsPayablePrepaidCurrent
10391000
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
54210000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
37789000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
108385000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
78944000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
175000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
171931000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
127299000
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4697000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
694000
CY2023Q3 us-gaap Liabilities
Liabilities
171936000
CY2022Q4 us-gaap Liabilities
Liabilities
132690000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
180883383
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
153798815
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
171656030
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
152839239
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
2000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
757006000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
611872000
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
27084568
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
18816791
CY2023Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
519635000
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
385010000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
11968000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
20723000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
416000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
236000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
249757000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
247823000
CY2023Q3 us-gaap Minority Interest
MinorityInterest
1169000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
1169000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
250926000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
248992000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
422862000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
381682000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1214513000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1238975000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3298056000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3664766000
CY2023Q3 expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
1130888000
CY2022Q3 expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
1145853000
expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
3044858000
expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
3380930000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
78568000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
89460000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
232876000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
256173000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3194000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3636000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9035000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11546000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1212650000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1238949000
us-gaap Operating Expenses
OperatingExpenses
3286769000
us-gaap Operating Expenses
OperatingExpenses
3648649000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1863000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
26000
us-gaap Operating Income Loss
OperatingIncomeLoss
11287000
us-gaap Operating Income Loss
OperatingIncomeLoss
16117000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
708000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
78000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2887000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-394000
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-354000
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-329000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-839000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1213000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
354000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-251000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2048000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1607000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2217000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-225000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13335000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14510000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
868000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4627000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1111000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8115000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
1349000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
4402000
us-gaap Profit Loss
ProfitLoss
12224000
us-gaap Profit Loss
ProfitLoss
22625000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-18000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1349000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
4402000
us-gaap Net Income Loss
NetIncomeLoss
12224000
us-gaap Net Income Loss
NetIncomeLoss
22643000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153392005
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151826315
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153065727
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150622845
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
158183888
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
155915307
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156834985
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156434440
CY2023Q3 us-gaap Profit Loss
ProfitLoss
1349000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
4402000
us-gaap Profit Loss
ProfitLoss
12224000
us-gaap Profit Loss
ProfitLoss
22625000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-18000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1349000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
4402000
us-gaap Net Income Loss
NetIncomeLoss
12224000
us-gaap Net Income Loss
NetIncomeLoss
22643000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-527000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-521000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
180000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1662000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
822000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3881000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12404000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20981000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
250926000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
257063000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
250926000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
257063000
us-gaap Profit Loss
ProfitLoss
12224000
us-gaap Profit Loss
ProfitLoss
22625000
us-gaap Depreciation
Depreciation
6299000
us-gaap Depreciation
Depreciation
5699000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1849000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1455000
us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
472000
us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
361000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
-2211000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
588000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-839000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1213000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
29912000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
22828000
expi Share Based Compensation Agent Equity Program
ShareBasedCompensationAgentEquityProgram
131230000
expi Deferred Tax Asset Change
DeferredTaxAssetChange
3435000
expi Deferred Tax Asset Change
DeferredTaxAssetChange
-10845000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
7659000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
10872000
expi Share Based Compensation Agent Equity Program
ShareBasedCompensationAgentEquityProgram
104548000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23401000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13603000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3966000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3003000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-16421000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
16135000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1069000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1952000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
28039000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4770000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4692000
expi Proceeds From Payments For Other Operating Activities
ProceedsFromPaymentsForOtherOperatingActivities
158000
expi Proceeds From Payments For Other Operating Activities
ProceedsFromPaymentsForOtherOperatingActivities
111000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
176516000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
187324000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4193000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9222000
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
330000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
9668000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
5525000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1930000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11318000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18890000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
134625000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
139635000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4761000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2221000
expi Payments To Proceeds From Noncontrolling Interests
PaymentsToProceedsFromNoncontrollingInterests
425000
us-gaap Payments Of Dividends
PaymentsOfDividends
20979000
us-gaap Payments Of Dividends
PaymentsOfDividends
18537000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-150843000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-156376000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
403000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-771000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14758000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11287000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159383000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175910000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
174141000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
187197000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2382000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2933000
expi Lease Termination Non Cash Investing And Financing Activities
LeaseTerminationNonCashInvestingAndFinancingActivities
855000
us-gaap Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1
4800000
expi Noncash Or Part Noncash Contingent Consideration For Disposition Of Business
NoncashOrPartNoncashContingentConsiderationForDispositionOfBusiness
1209000
expi Property Plant And Equipment Increase Due To Transfer Of Lease Asset
PropertyPlantAndEquipmentIncreaseDueToTransferOfLeaseAsset
1100000
expi Property Plant And Equipment Purchases In Accounts Payable
PropertyPlantAndEquipmentPurchasesInAccountsPayable
27000
expi Property Plant And Equipment Purchases In Accounts Payable
PropertyPlantAndEquipmentPurchasesInAccountsPayable
20000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Roboto';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimate</span>s</p><p style="font-family:'Roboto';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowance for credit losses, legal contingencies, income taxes, revenue recognition, stock-based compensation, goodwill, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Roboto';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Reclassifications</span></p><p style="font-family:'Roboto';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">When necessary, the Company will reclassify certain amounts in prior-period financial statements to conform to the current period’s presentation. No reclassifications occurred during the current period.</p>
CY2023Q3 expi Property Plant And Equipment Excluding Assets Under Construction
PropertyPlantAndEquipmentExcludingAssetsUnderConstruction
13105000
CY2022Q4 expi Property Plant And Equipment Excluding Assets Under Construction
PropertyPlantAndEquipmentExcludingAssetsUnderConstruction
14944000
CY2023Q3 expi Assets Under Development
AssetsUnderDevelopment
757000
CY2022Q4 expi Assets Under Development
AssetsUnderDevelopment
3207000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13862000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18151000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108237000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
67673000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175910000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
134545000
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
52652000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
187197000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121594000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
37789000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159383000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120141000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
54000000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
174141000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
38780000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34226000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25675000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19282000
CY2023Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2761943
CY2022Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
4716026
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
8257049
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
9452025
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2136000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2129000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6299000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5699000
CY2023Q3 us-gaap Goodwill
Goodwill
24879000
CY2022Q4 us-gaap Goodwill
Goodwill
27212000
CY2023Q3 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
-2310000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
17155000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5697000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11458000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12856000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4156000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8700000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
654000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
638000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1849000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1455000
CY2023Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
177900083
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
163286569
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
171656030
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155516284
CY2023Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
610132
CY2022Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
681139
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
802939
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2044193
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
180883383
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
168562464
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
180883383
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
168562464
CY2022Q4 expi Stock Compensation Liability Activity
StockCompensationLiabilityActivity
3885000
expi Increase Decrease In Stock Grant Liability
IncreaseDecreaseInStockGrantLiability
2796000
expi Stock Grants Reclassified From Liability To Equity
StockGrantsReclassifiedFromLiabilityToEquity
1094000
CY2023Q3 expi Stock Compensation Liability Activity
StockCompensationLiabilityActivity
5587000
CY2018Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
25000000.0
CY2019Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000.0
CY2019Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000.0
CY2020Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
400000000.0
CY2020Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
400000000.0
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000.0
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000.0
CY2023Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000000.0
CY2022Q1 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
10000000.0
CY2022Q1 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
10000000.0
CY2022Q2 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
20000000.0
CY2022Q2 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
20000000.0
CY2022Q3 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
13300000
CY2022Q3 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
13300000
CY2022Q4 expi Stock Repurchase Program Authorized Amount Per Month
StockRepurchaseProgramAuthorizedAmountPerMonth
10000000.0
CY2023Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000.0
CY2023Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000000.0
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
24311897
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
11487691
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
18816791
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6751692
CY2023Q3 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
10728
us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
10728
CY2022Q3 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
343331
us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
343331
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
27084568
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15860386
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
27084568
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15860386
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1349000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
4402000
us-gaap Net Income Loss
NetIncomeLoss
12224000
us-gaap Net Income Loss
NetIncomeLoss
22643000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153392005
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151826315
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153065727
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150622845
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4791883
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4088992
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3769258
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5811595
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
158183888
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
155915307
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156834985
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156434440
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
192684
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1315861
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
679425
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
845162
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1111000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8115000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0831
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.5622
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1214513000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1238975000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3298056000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3664766000
CY2023Q3 expi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
18950000
CY2022Q3 expi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
12349000
expi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
57006000
expi Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
56971000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2790000
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2767000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8148000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7154000
CY2023Q3 expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
11764000
CY2022Q3 expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
5800000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
29912000
expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
22828000
CY2023Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
2533000
CY2022Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
3756000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
7659000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
10872000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1863000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
26000
us-gaap Operating Income Loss
OperatingIncomeLoss
11287000
us-gaap Operating Income Loss
OperatingIncomeLoss
16117000
CY2023Q3 us-gaap Goodwill
Goodwill
24879000
CY2022Q4 us-gaap Goodwill
Goodwill
27212000

Files In Submission

Name View Source Status
expi-20230930_cal.xml Edgar Link unprocessable
expi-20230930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001558370-23-017439-index-headers.html Edgar Link pending
0001558370-23-017439-index.html Edgar Link pending
0001558370-23-017439.txt Edgar Link pending
0001558370-23-017439-xbrl.zip Edgar Link pending
expi-20230930.xsd Edgar Link pending
expi-20230930x10q.htm Edgar Link pending
expi-20230930x10q001.jpg Edgar Link pending
expi-20230930xex31d1.htm Edgar Link pending
expi-20230930xex31d2.htm Edgar Link pending
expi-20230930xex32d1.htm Edgar Link pending
expi-20230930xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
expi-20230930_pre.xml Edgar Link unprocessable
expi-20230930_lab.xml Edgar Link unprocessable
expi-20230930x10q_htm.xml Edgar Link completed
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending